Home > Insider Trading > Filing (0000899243-19-025205)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1781983	Aprea Therapeutics Inc.	APRE	()	DE

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1645161	Healthcap Vii, L.p.	C/O Healthcap Vii Gp S.a. 18 Avenue Of D'Ouchy Lausanne V8 CH-1006		No	No	Yes	No
1790047	S.a. Gp Vii Healthcap	C/O Healthcap Vii Gp S.a., 18 Avenue Of D'Ouchy Lausanne V8 CH-1006		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-10-07	1,661,382	$0.00	1,671,941	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2019-10-07	427,496	$0.00	2,099,437	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2019-10-07	266,667	$15.00	2,366,104	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See footnote
No	4	C	Indirect	See footnote
No	4	P	Indirect	See footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series B Convertible Preferred Stock	Disposition	2019-10-07	1,661,382	$0.00	1,661,382	$0.00
Common Stock	Series C Convertible Preferred Stock	Disposition	2019-10-07	427,496	$0.00	427,496	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect
0			No	4	C	Indirect

Footnotes

Immediately prior the closing of the Issuer's initial public offering the shares of preferred stock automatically converted into shares of the common stock. Each share of preferred stock was convertible into shares of common stock at any time at the option of the holder and had no expiration date.
The securities are directly held by HealthCap VII L.P. (the "Fund"). HealthCap VII GP S.A. (the "General Partner") is the sole general partner of the Fund. The General Partner disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of its indirect pecuniary interest therein, and this report shall not be deemed an admission that the General Partner is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.